N-(1,3-benzodioxol-5-yl)naphthalene-2-carboxamide结构式
|
常用名 | N-(1,3-benzodioxol-5-yl)naphthalene-2-carboxamide | 英文名 | N-(1,3-benzodioxol-5-yl)naphthalene-2-carboxamide |
|---|---|---|---|---|
| CAS号 | 306745-36-8 | 分子量 | 291.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H13NO3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(1,3-benzodioxol-5-yl)naphthalene-2-carboxamide |
|---|
| 分子式 | C18H13NO3 |
|---|---|
| 分子量 | 291.3 |
| InChIKey | DBVBCJQAOPQWLE-UHFFFAOYSA-N |
| SMILES | C1OC2=C(O1)C=C(C=C2)NC(=O)C3=CC4=CC=CC=C4C=C3 |
|
实验名称:Late stage counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, g...
来源:The Scripps Research Institute Molecular Screening Center
靶标:nuclear receptor subfamily 0 group B member 1 [Homo sapiens]
External Id:GAL4_INH_LUMI_1536_3XIC50 MDCSRUN DAX1
|
|
实验名称:Late stage luminescence-based cell-based dose response assay for inhibitors of the or...
来源:The Scripps Research Institute Molecular Screening Center
靶标:nuclear receptor subfamily 0 group B member 1 [Homo sapiens]
External Id:DAX1_INH_LUMI_1536_3XIC50 MDRUN
|